

In December 2020, the French government launched a mass COVID-19 screening campaign in France to control the spread of the disease.More than 60,000 businesses enrolled under this program for the on-site testing of their workers.
Molecular diagnostics market size free#
The government also provided free testing kits as a part of its workplace testing program for businesses that cannot afford on-site testing kits. Government made COVID-19 testing mandatory for all workplaces and businesses with over ten employees. Government made it mandatory for all incoming passengers to carry a negative COVID-19 test report or proof of recovery from the disease amidst the rising number of cases of the Omicron variant.

Impact of COVID-19 on the Molecular Diagnostics Market However, unfavorable regulatory frameworks and the high costs of molecular diagnostic tests restrain the growth of this market. The growth of this market is driven by the rising global geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. The molecular diagnostics market comprises advanced products and technologies used by medical professionals for patient management, from diagnosis to treatment, primarily focusing on areas such as infectious disease and cancer. The Molecular Diagnostics Market is projected to reach $46.69 billion by 2030, at a CAGR of 5.6% from 2023 to 2030.
